Results of the votes of the Combined Shareholders’ Meeting of May 19, 2022
May 20, 2022 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, United States), May 20, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the...
Résultats des votes de l’Assemblée Générale Mixte des actionnaires réunie le 19 mai 2022
May 20, 2022 16:00 ET | INVENTIVA
Daix (France), Long Island City (New York, Etats-Unis), le 20 mai 2022 – Inventiva (Euronext Paris et Nasdaq : IVA), société́ biopharmaceutique spécialisée dans le développement clinique de petites...
GrowcentiaLogo.png
Growcentia, a leading provider of scientifically driven biological solutions for agriculture and horticulture, celebrates grand opening of new Colorado HQ in Loveland’s Centerra area
May 20, 2022 11:34 ET | Growcentia
LOVELAND, Colo., May 20, 2022 (GLOBE NEWSWIRE) -- Growcentia®, a Colorado-based biological agtech company producing science-based soil-enhancement solutions under the Mammoth® product line, today...
Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022
May 19, 2022 16:00 ET | INVENTIVA
Daix, May 19, 2022 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of this description is to present the objectives and...
DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS AUTORISÉ PAR L'ASSEMBLÉE GÉNÉRALE ORDINAIRE DU 19 MAI 2022  
May 19, 2022 16:00 ET | INVENTIVA
Daix, le 19 mai 2022  En application de l'article 241-2 du Règlement Général de l’Autorité des marchés financiers (AMF), le présent descriptif a pour finalité de présenter les objectifs ainsi que...
Kane Logo Cropped TransBG.png
Kane Biotech to Release First Quarter 2022 Financial Results on May 26 – Conference Call to Follow
May 19, 2022 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 19, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Obtains ISO 13485 Certification
May 18, 2022 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), announced today that it has obtained ISO 13485:2016 certification...
Celyad-Logo-Color.jpg
Celyad Oncology to Present at the H.C. Wainwright Global Investment Conference
May 17, 2022 16:05 ET | Celyad Oncology SA
MONT-SAINT-GUIBERT, Belgium, May 17, 2022 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext & Nasdaq: CYAD) (the “Company”), a clinical-stage biotechnology company focused on the discovery and...
Phathom_Pharm_Logo_RGB.jpg
Phathom Pharmaceuticals to Present Data at DDW 2022 Annual Meeting
May 17, 2022 08:01 ET | Phathom Pharmaceuticals
New investigational data evaluating vonoprazan in erosive esophagitis (EE) Research highlights real-world evidence of unmet needs that exists for the treatment of Helicobacter pylori (H. pylori)...
OBI Logo.jpg
OBI Pharma Announces Poster Presentations at the 2022 ASCO Annual Meeting for Adagloxad Simolenin, OBI-999, OBI-3424, and Exhibition Booth
May 17, 2022 05:00 ET | OBI Pharma Inc.
TAIPEI, Taiwan, May 17, 2022 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174), a leader in First-in-Class Cancer therapeutics, today announced that data highlighting ongoing clinical studies...